An Exciting Collaborative Funding for the Petitjean and Mulligan groups
Mulligan and Petitjean groups secure one of the four 2019 provincial Cancer Therapeutics Innovation Pipeline grants from the Ontario Institute for Cancer Research to collaboratively work on the regulation of the RET protein. CongRETulations!
